Foghorn’s Phase I AML/MDS trial on FDA partial clinical hold due to subject death
No new subjects will be enrolled in the trial until the FDA lifts the partial clinical hold.
Company News
Latest in
Company News
Indaptus to commence Phase I trial of solid tumour therapy
The company received FDA clearance for the IND application to initiate the trial.
Headlands, Pfizer collaborate to boost clinical trial diversity
Under the collaboration, the first trial site will be opened at a new facility of Headlands in Brownsville, Texas, US.
Suvoda announces availability of eConsent to simplify trial consent process
eConsent offers the flexibility to include differences in regulations by country, consent methods, consent types and device needs.
AIM ImmunoTech provides Phase III efficacy update on Ampligen for long Covid
Treatment with investigational drug Ampligen for a minimum of 12 weeks offered a decline in fatigue in long Covid patients.
Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
Humanetics extends long Covid drug trial to more sites
The trial will analyse BIO 300’s ability to alleviate long-term pulmonary damage in Covid-19 survivors.
Imugene, City of Hope doses first subject in Phase I solid tumour trial
The trial will assess the safety and tolerability of oncolytic virus CF33-hNIS as monotherapy or along with pembrolizumab.